يحاول ذهب - حر

analytica Lab India concludes on record-breaking note

October 16, 2025

|

Chronicle Pharmabiz

HYDERABAD witnessed a remarkable convergence of science, technology, and business as analytica Lab India and Pharma Pro&Pack Expo 2025 unfolded at the HITEX Exhibition Centre.

- By Our Bureau, Mumbai

For three days, the venue transformed into a buzzing hub of innovation, where ideas travelled as freely as people, and the boundaries between research, industry, and global collaboration blurred seamlessly.

Spread across 7 halls covering an impressive 50,000+ square metres, the co-located fairs featured 650+ exhibitors presenting more than 10,000 breakthrough products and solutions.

From advanced laboratory instruments to state-of-the-art pharmaceutical machinery, the exhibition floor offered a panoramic view of how technology is redefining India's role in the life sciences and pharmaceutical value chain.

Drawing over 32,149 visitors from India and abroad, the event lived up to its theme - "Epicentre of Progress." It wasn't just about the scale of participation; it was about the quality of conversations, the deals struck in meeting rooms, and the curiosity sparked in conference halls. From leading pharma manufacturers and pioneering researchers to startups and policy makers, the gathering reflected the ecosystem's collective drive toward efficiency, sustainability, and global competitiveness.

Among the most engaging features was the Software Pavilion, which offered a glimpse into the future of digital labs and smart factories. Here, visitors explored the impact of AI, machine learning, robotics, IoT, and automation on everything from compliance frameworks to production efficiency - technologies that are already rewriting the rules of modern laboratories and pharmaceutical plants.

المزيد من القصص من Chronicle Pharmabiz

Chronicle Pharmabiz

Chronicle Pharmabiz

Home-grown CAR-T cell therapies gaining ground

INDIAN biotech and pharmaceutical companies are actively working on innovative solutions to make CART cell therapy both accessible and cost-effective.

time to read

4 mins

November 27, 2025

Chronicle Pharmabiz

NPPA extends price fixation on orthopaedic implants for 1 year

IN a move that will disappoint the industry, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation it imposed on orthopaedic knee implants for knee replacement system for one more year.

time to read

1 mins

November 27, 2025

Chronicle Pharmabiz

FICCI envisages it's Smart AAMs to boost healthcare

In line with the Central Government's vision of comprehensive primary healthcare, FICCI Swasth Bharat Task Force has undertaken a transformative initiative titled 'Smart Ayushman Arogya Mandirs-AAMs' (earlier called Health & Wellness Centres) aimed at strengthening the primary healthcare delivery system across India.

time to read

1 min

November 27, 2025

Chronicle Pharmabiz

DoP asked to bring policy for affordable drug pricing

THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DoP) to take steps to come out with a pharmaceutical policy with thrust to provide both scheduled and nonscheduled formulations at affordable prices.

time to read

1 mins

November 27, 2025

Chronicle Pharmabiz

Ramaiah emphasises need for bone health and osteoporosis diagnosis

RAMAIAH Memorial Hospital (RMH), a multi-superspecialty quaternary care hospitals emphasises on bone health and osteoporosis diagnosis. It calls for timely screening and diagnosis through the new and advanced DXA scanner with superior and accurate test results.

time to read

2 mins

November 27, 2025

Chronicle Pharmabiz

Nathealth calls for action in 2026-27 Union Budget

NATHEALTH has submitted its budget 2026-27 recommendations to the Union government, outlining a roadmap to strengthen healthcare delivery, foster innovation, and expand insurance and preventive coverage.

time to read

1 mins

November 27, 2025

Chronicle Pharmabiz

Hotspots & growth opportunities in biomanufacturing

THE Indian bioeconomy has grown from US$ 10 billion in 2014 to US$ 165.7 billion in 2024, and is likely reach US$ 300 billion by 2030.

time to read

3 mins

November 27, 2025

Chronicle Pharmabiz

Omega Hospitals acquires Cytecare Hospitals

Morgan Stanley PE backed Hyderabad-based Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru.

time to read

2 mins

November 27, 2025

Chronicle Pharmabiz

Devices sector hails withdrawal of QCOs

THE medical devices manufacturers industry in the country has welcomed the Central government's decision to withdraw multiple Quality Control Orders (QCOs) imposed on essential raw materials across various industries, including the medical devices sector.

time to read

1 min

November 27, 2025

Chronicle Pharmabiz

'There is urgent need for tech-focused regulatory approach for med devices'

THE Indian healthcare industry has evolved at a breakneck pace, but its regulatory framework has struggled to keep up to its speed of development.

time to read

2 mins

November 27, 2025

Listen

Translate

Share

-
+

Change font size